SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
867.00    15.00 (1.76%)
Bid:
867.00
Ask:
873.00
Spread: 6.00 (0.692%)
Market Cap: £515.62m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Update Statement on 2024 AGM Voting Results

13 Dec 2024 07:00

RNS Number : 9331P
Pollen Street Group Limited
13 December 2024
 

13 December 2024

Pollen Street Group Limited

("Pollen Street Group" or the "Company")

Update Statement on 2024 Annual General Meeting Voting Results

 

Pollen Street Group Limited ("Pollen Street Group" or the "Company") today provides an update in respect of its Annual General Meeting held on 13 June 2024 ("AGM"). As previously announced, at the AGM all resolutions were successfully passed with the requisite majority of votes. However, the Company acknowledges that resolutions 18 and 19 ("The Rule 9 Waiver Resolutions") received a lower level of support (of votes cast, 79.73% and 66.8% voted in favour respectively).

The Rule 9 Waiver Resolutions related to the approval by independent shareholders of a waiver obtained from the Panel on Takeovers and Mergers in respect of an obligation that could arise on the Concert Party (as defined in the Notice of AGM 20 May 2024), to make a general offer for all the issued ordinary share capital of the Company following any increase in the percentage of shares held by the Concert Party resulting from either the exercise by the Company of the authority to purchase its own shares pursuant to resolutions 14 (which received approval from 98.89% those voting) or resulting from the 2025 Awards Grant (as defined in the Notice of Meeting 20 May 2024).

Since the AGM, the Company and Board have engaged with shareholders to understand their voting decisions and discuss the rationale behind the relevant resolutionsThe Board believes that it is in the best interest of the shareholders that the Company has the flexibility to return value to the shareholders through buyback schemes, and the Concert Party remains fully supportive of the Company's management and has no intention to make any changes to the future of the Company. 

The Board encourages ongoing shareholder and proxy adviser engagement and continues to make itself available to all stakeholders on request. The Board will again take the views of shareholders into account ahead of tabling resolutions at the next AGM and continues to engage regularly with shareholders and their representative bodies. In accordance with the UK Corporate Governance Code, any further updates will be provided in the Company's 2024 annual report and accounts.

For further information about this announcement please contact:

Pollen Street Group Limited

Corporate Development Director

Shweta.Chugh@pollencap.com

+44 (0) 7813 58 1377

Link Company Matters Limited

Company Secretary

Polncosec@linkgroup.co.uk

FGS Global

Communications Advisor

Chris.sibbald@fgsglobal.com

+44 (0) 7855 95 5531

Barclays Bank plc

Joint broker

Neal West / Stuart Muress

+44 (0) 20 7623 2323

Investec Bank plc

Joint broker

Ben Griffiths / Kamalini Hull

+44 (0) 20 7597 4000

 

 

LEI: 894500LP94M98N8CY487

 

About Pollen Street Group Limited

Pollen Street is an alternative asset manager dedicated to investing within the financial and business services sectors across both Private Equity and Private Credit strategies. The business was founded in 2013 and has consistently delivered top tier returns alongside growing AuM. 

 

Pollen Street benefits from a complementary set of asset management activities focused on managing third-party AuM (the "Asset Manager") together with on-balance sheet investments (the "Investment Company").

 

The Asset Manager raises capital from high quality investors and deploys it into its Private Equity and Private Credit strategies. The strong recurring revenues from this business enable delivery of scalable growth.

 

The Investment Company invests in the strategies of the group delivering attractive risk adjusted returns and accelerating growth in third-party AuM of the Asset Manager through investing in Pollen Street funds, taking advantage of attractive investment opportunities and aligning interest with our investors to grow AuM. Today the portfolio is largely invested in credit assets with the allocation to Private Equity expect to increase to 30 per cent in the long term. The portfolio consists of both direct investments and investments in funds managed by Pollen Street.

 

POLN is listed on the London Stock Exchange (ticker symbol: POLN). Further details are available at www.pollenstreetgroup.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDQKBBDOBDDFBD
Date   Source Headline
1st Jun 20263:01 pmRNSTotal Voting Rights
27th May 20264:46 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:39 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSQ1 2026 Trading Update
6th May 20264:40 pmRNSDirector/PDMR Shareholding
1st May 20269:49 amRNSTotal Voting Rights
1st May 20268:12 amRNSResult of AGM
28th Apr 20264:31 pmRNSDirector/PDMR Shareholding
16th Apr 20265:31 pmRNSInvestor Presentation via Investor Meet Company
14th Apr 20267:00 amRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
27th Mar 202610:36 amRNSDirector/PDMR Shareholding
26th Mar 20264:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:30 amRNSDividend Declaration
26th Mar 20267:00 amRNSFull Year 2025 Trading Update
2nd Mar 202611:26 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20261:57 pmRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20264:32 pmRNSDirector/PDMR Shareholding
2nd Feb 20263:12 pmRNSTotal Voting Rights
30th Jan 202610:59 amRNSDirectorate changes
28th Jan 202611:37 amRNSDirector/PDMR Shareholding
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSDirectorate change
23rd Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 20254:27 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20259:50 amRNSUpdate Statement on 2025 AGM Voting Results
1st Dec 202511:15 amRNSTotal Voting Rights
28th Nov 20256:23 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSQ3 2025 Trading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSAnnouncement of New Share Buyback Programme
16th Oct 20256:16 pmRNSHolding(s) in Company
3rd Oct 202511:32 amRNSDirector/PDMR Shareholding
1st Oct 20255:12 pmRNSDirector/PDMR Shareholding
30th Sep 20254:07 pmRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.